nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP3A5—Propranolol—migraine	0.0547	0.0728	CbGbCtD
Lapatinib—CYP2C19—Timolol—migraine	0.0495	0.0659	CbGbCtD
Lapatinib—CYP3A5—Amitriptyline—migraine	0.0473	0.063	CbGbCtD
Lapatinib—CYP2C8—Amitriptyline—migraine	0.0455	0.0606	CbGbCtD
Lapatinib—CYP2C19—Propranolol—migraine	0.0442	0.0587	CbGbCtD
Lapatinib—CYP3A5—Valproic Acid—migraine	0.0431	0.0574	CbGbCtD
Lapatinib—CYP2C8—Valproic Acid—migraine	0.0415	0.0552	CbGbCtD
Lapatinib—ABCB1—Timolol—migraine	0.04	0.0532	CbGbCtD
Lapatinib—CYP2C19—Amitriptyline—migraine	0.0382	0.0508	CbGbCtD
Lapatinib—CYP3A5—Verapamil—migraine	0.0376	0.05	CbGbCtD
Lapatinib—CYP2C8—Verapamil—migraine	0.0361	0.0481	CbGbCtD
Lapatinib—ABCB1—Propranolol—migraine	0.0356	0.0474	CbGbCtD
Lapatinib—CYP2C19—Valproic Acid—migraine	0.0348	0.0463	CbGbCtD
Lapatinib—CYP2C19—Topiramate—migraine	0.0314	0.0418	CbGbCtD
Lapatinib—ABCB1—Amitriptyline—migraine	0.0308	0.041	CbGbCtD
Lapatinib—CYP2C19—Verapamil—migraine	0.0303	0.0403	CbGbCtD
Lapatinib—ABCB1—Verapamil—migraine	0.0245	0.0325	CbGbCtD
Lapatinib—CYP3A4—Propranolol—migraine	0.0213	0.0284	CbGbCtD
Lapatinib—CYP3A4—Amitriptyline—migraine	0.0185	0.0246	CbGbCtD
Lapatinib—CYP3A4—Valproic Acid—migraine	0.0168	0.0224	CbGbCtD
Lapatinib—CYP3A4—Topiramate—migraine	0.0152	0.0202	CbGbCtD
Lapatinib—CYP3A4—Verapamil—migraine	0.0146	0.0195	CbGbCtD
Lapatinib—TAP1—trigeminal ganglion—migraine	0.00458	0.0718	CbGeAlD
Lapatinib—PIK3C2B—trigeminal ganglion—migraine	0.0043	0.0675	CbGeAlD
Lapatinib—ERBB2—neck—migraine	0.00387	0.0607	CbGeAlD
Lapatinib—PI4KB—trigeminal ganglion—migraine	0.00313	0.0491	CbGeAlD
Lapatinib—ERBB4—brainstem—migraine	0.00296	0.0464	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—migraine	0.00242	0.0379	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—migraine	0.00242	0.0379	CbGeAlD
Lapatinib—PIK3C2B—head—migraine	0.0021	0.033	CbGeAlD
Lapatinib—TAP1—cerebellum—migraine	0.002	0.0313	CbGeAlD
Lapatinib—PIK3C2B—nervous system—migraine	0.00199	0.0313	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—migraine	0.00192	0.0301	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—migraine	0.00188	0.0294	CbGeAlD
Lapatinib—ERBB2—head—migraine	0.00164	0.0257	CbGeAlD
Lapatinib—ERBB4—head—migraine	0.00164	0.0257	CbGeAlD
Lapatinib—TAP1—brain—migraine	0.00162	0.0255	CbGeAlD
Lapatinib—TAP1—Mecp2 and Associated Rett Syndrome—BDNF—migraine	0.00156	0.0597	CbGpPWpGaD
Lapatinib—ERBB2—nervous system—migraine	0.00155	0.0243	CbGeAlD
Lapatinib—ERBB4—nervous system—migraine	0.00155	0.0243	CbGeAlD
Lapatinib—PI4KB—head—migraine	0.00153	0.024	CbGeAlD
Lapatinib—PIK3C2B—brain—migraine	0.00152	0.0239	CbGeAlD
Lapatinib—ERBB2—central nervous system—migraine	0.00149	0.0234	CbGeAlD
Lapatinib—ERBB4—central nervous system—migraine	0.00149	0.0234	CbGeAlD
Lapatinib—PIK3C2B—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.00149	0.0571	CbGpPWpGaD
Lapatinib—ERBB2—cerebellum—migraine	0.00146	0.0229	CbGeAlD
Lapatinib—ERBB4—cerebellum—migraine	0.00146	0.0229	CbGeAlD
Lapatinib—PI4KB—nervous system—migraine	0.00145	0.0228	CbGeAlD
Lapatinib—EGFR—EGFR-dependent Endothelin signaling events—EDNRA—migraine	0.00144	0.0554	CbGpPWpGaD
Lapatinib—PI4KB—central nervous system—migraine	0.0014	0.0219	CbGeAlD
Lapatinib—PI4KB—cerebellum—migraine	0.00137	0.0214	CbGeAlD
Lapatinib—EGFR—cerebellum—migraine	0.00124	0.0194	CbGeAlD
Lapatinib—Alopecia—Amitriptyline—migraine	0.00123	0.00777	CcSEcCtD
Lapatinib—ERBB2—brain—migraine	0.00119	0.0186	CbGeAlD
Lapatinib—ERBB4—brain—migraine	0.00119	0.0186	CbGeAlD
Lapatinib—PI4KB—Integrins in angiogenesis—TGFBR2—migraine	0.00116	0.0445	CbGpPWpGaD
Lapatinib—PI4KB—brain—migraine	0.00111	0.0174	CbGeAlD
Lapatinib—Leukopenia—Amitriptyline—migraine	0.00109	0.00685	CcSEcCtD
Lapatinib—Palpitations—Amitriptyline—migraine	0.00107	0.00676	CcSEcCtD
Lapatinib—Cardiac disorder—Propranolol—migraine	0.00105	0.00664	CcSEcCtD
Lapatinib—EGFR—brain—migraine	0.00101	0.0158	CbGeAlD
Lapatinib—Alopecia—Propranolol—migraine	0.001	0.00633	CcSEcCtD
Lapatinib—Mental disorder—Propranolol—migraine	0.000994	0.00627	CcSEcCtD
Lapatinib—Dry skin—Valproic Acid—migraine	0.000981	0.00619	CcSEcCtD
Lapatinib—Cardiac failure—Timolol—migraine	0.000976	0.00616	CcSEcCtD
Lapatinib—ERBB4—EV release from cardiac cells and their functional effects—TNF—migraine	0.000976	0.0374	CbGpPWpGaD
Lapatinib—Renal failure acute—Gabapentin—migraine	0.000961	0.00606	CcSEcCtD
Lapatinib—ERBB4—Nuclear signaling by ERBB4—PGR—migraine	0.000954	0.0366	CbGpPWpGaD
Lapatinib—Pain in extremity—Timolol—migraine	0.000952	0.00601	CcSEcCtD
Lapatinib—Anorexia—Amitriptyline—migraine	0.000944	0.00595	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Valproic Acid—migraine	0.000944	0.00595	CcSEcCtD
Lapatinib—Alopecia—Verapamil—migraine	0.000922	0.00582	CcSEcCtD
Lapatinib—Cardiac failure—Gabapentin—migraine	0.000909	0.00573	CcSEcCtD
Lapatinib—Insomnia—Amitriptyline—migraine	0.000896	0.00565	CcSEcCtD
Lapatinib—Pain in extremity—Gabapentin—migraine	0.000887	0.00559	CcSEcCtD
Lapatinib—ERBB2—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.000884	0.0339	CbGpPWpGaD
Lapatinib—Dyspepsia—Amitriptyline—migraine	0.000872	0.0055	CcSEcCtD
Lapatinib—Neutropenia—Valproic Acid—migraine	0.000865	0.00545	CcSEcCtD
Lapatinib—Cough—Propranolol—migraine	0.000862	0.00544	CcSEcCtD
Lapatinib—Decreased appetite—Amitriptyline—migraine	0.000861	0.00543	CcSEcCtD
Lapatinib—Fatigue—Amitriptyline—migraine	0.000854	0.00538	CcSEcCtD
Lapatinib—Constipation—Amitriptyline—migraine	0.000847	0.00534	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000835	0.00527	CcSEcCtD
Lapatinib—Pneumonia—Valproic Acid—migraine	0.000829	0.00523	CcSEcCtD
Lapatinib—Dehydration—Gabapentin—migraine	0.000825	0.0052	CcSEcCtD
Lapatinib—Dry skin—Gabapentin—migraine	0.000813	0.00513	CcSEcCtD
Lapatinib—Anaphylactic shock—Propranolol—migraine	0.000806	0.00509	CcSEcCtD
Lapatinib—Stomatitis—Valproic Acid—migraine	0.000804	0.00507	CcSEcCtD
Lapatinib—Palpitations—Verapamil—migraine	0.000803	0.00507	CcSEcCtD
Lapatinib—Infection—Propranolol—migraine	0.000801	0.00505	CcSEcCtD
Lapatinib—Hot flush—Topiramate—migraine	0.000798	0.00503	CcSEcCtD
Lapatinib—Menopausal symptoms—Topiramate—migraine	0.000791	0.00499	CcSEcCtD
Lapatinib—Nervous system disorder—Propranolol—migraine	0.000791	0.00499	CcSEcCtD
Lapatinib—Skin disorder—Propranolol—migraine	0.000783	0.00494	CcSEcCtD
Lapatinib—Hepatobiliary disease—Valproic Acid—migraine	0.00078	0.00492	CcSEcCtD
Lapatinib—Epistaxis—Valproic Acid—migraine	0.000778	0.00491	CcSEcCtD
Lapatinib—Arthralgia—Verapamil—migraine	0.000774	0.00488	CcSEcCtD
Lapatinib—Myalgia—Verapamil—migraine	0.000774	0.00488	CcSEcCtD
Lapatinib—Pain in extremity—Topiramate—migraine	0.000746	0.00471	CcSEcCtD
Lapatinib—Anaphylactic shock—Verapamil—migraine	0.000742	0.00468	CcSEcCtD
Lapatinib—Infection—Verapamil—migraine	0.000737	0.00465	CcSEcCtD
Lapatinib—Insomnia—Propranolol—migraine	0.000729	0.0046	CcSEcCtD
Lapatinib—Connective tissue disorder—Valproic Acid—migraine	0.000727	0.00459	CcSEcCtD
Lapatinib—Dyspnoea—Propranolol—migraine	0.000719	0.00453	CcSEcCtD
Lapatinib—Asthenia—Amitriptyline—migraine	0.00071	0.00448	CcSEcCtD
Lapatinib—Dyspepsia—Propranolol—migraine	0.00071	0.00448	CcSEcCtD
Lapatinib—ABCB1—blood vessel—migraine	0.000706	0.0111	CbGeAlD
Lapatinib—Decreased appetite—Propranolol—migraine	0.000701	0.00442	CcSEcCtD
Lapatinib—Pruritus—Amitriptyline—migraine	0.000701	0.00442	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Propranolol—migraine	0.000696	0.00439	CcSEcCtD
Lapatinib—Fatigue—Propranolol—migraine	0.000695	0.00438	CcSEcCtD
Lapatinib—Dehydration—Topiramate—migraine	0.000694	0.00438	CcSEcCtD
Lapatinib—Epistaxis—Timolol—migraine	0.000692	0.00437	CcSEcCtD
Lapatinib—Constipation—Propranolol—migraine	0.000689	0.00435	CcSEcCtD
Lapatinib—Pneumonia—Gabapentin—migraine	0.000687	0.00434	CcSEcCtD
Lapatinib—Infestation—Gabapentin—migraine	0.000683	0.00431	CcSEcCtD
Lapatinib—Infestation NOS—Gabapentin—migraine	0.000683	0.00431	CcSEcCtD
Lapatinib—Diarrhoea—Amitriptyline—migraine	0.000677	0.00427	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Verapamil—migraine	0.000676	0.00426	CcSEcCtD
Lapatinib—Angiopathy—Valproic Acid—migraine	0.000671	0.00424	CcSEcCtD
Lapatinib—Insomnia—Verapamil—migraine	0.000671	0.00423	CcSEcCtD
Lapatinib—Neuropathy peripheral—Gabapentin—migraine	0.00067	0.00423	CcSEcCtD
Lapatinib—Immune system disorder—Valproic Acid—migraine	0.000669	0.00422	CcSEcCtD
Lapatinib—Mediastinal disorder—Valproic Acid—migraine	0.000667	0.00421	CcSEcCtD
Lapatinib—Stomatitis—Gabapentin—migraine	0.000666	0.0042	CcSEcCtD
Lapatinib—Dyspnoea—Verapamil—migraine	0.000661	0.00417	CcSEcCtD
Lapatinib—Gastrointestinal pain—Propranolol—migraine	0.000659	0.00416	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Topiramate—migraine	0.000658	0.00415	CcSEcCtD
Lapatinib—Alopecia—Valproic Acid—migraine	0.000654	0.00413	CcSEcCtD
Lapatinib—Dyspepsia—Verapamil—migraine	0.000653	0.00412	CcSEcCtD
Lapatinib—Mental disorder—Valproic Acid—migraine	0.000648	0.00409	CcSEcCtD
Lapatinib—Connective tissue disorder—Timolol—migraine	0.000647	0.00408	CcSEcCtD
Lapatinib—Hepatobiliary disease—Gabapentin—migraine	0.000646	0.00408	CcSEcCtD
Lapatinib—Epistaxis—Gabapentin—migraine	0.000645	0.00407	CcSEcCtD
Lapatinib—Malnutrition—Valproic Acid—migraine	0.000644	0.00406	CcSEcCtD
Lapatinib—Fatigue—Verapamil—migraine	0.000639	0.00403	CcSEcCtD
Lapatinib—Abdominal pain—Propranolol—migraine	0.000637	0.00402	CcSEcCtD
Lapatinib—Constipation—Verapamil—migraine	0.000634	0.004	CcSEcCtD
Lapatinib—Vomiting—Amitriptyline—migraine	0.00063	0.00397	CcSEcCtD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—LRP1—migraine	0.000629	0.0241	CbGpPWpGaD
Lapatinib—Rash—Amitriptyline—migraine	0.000624	0.00394	CcSEcCtD
Lapatinib—Dermatitis—Amitriptyline—migraine	0.000624	0.00393	CcSEcCtD
Lapatinib—Back pain—Valproic Acid—migraine	0.000623	0.00393	CcSEcCtD
Lapatinib—Headache—Amitriptyline—migraine	0.00062	0.00391	CcSEcCtD
Lapatinib—Cardiac disorder—Timolol—migraine	0.000611	0.00386	CcSEcCtD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000606	0.0233	CbGpPWpGaD
Lapatinib—Neutropenia—Topiramate—migraine	0.000603	0.0038	CcSEcCtD
Lapatinib—Connective tissue disorder—Gabapentin—migraine	0.000603	0.0038	CcSEcCtD
Lapatinib—Angiopathy—Timolol—migraine	0.000598	0.00377	CcSEcCtD
Lapatinib—Anaemia—Valproic Acid—migraine	0.000595	0.00376	CcSEcCtD
Lapatinib—Immune system disorder—Timolol—migraine	0.000595	0.00375	CcSEcCtD
Lapatinib—Hypersensitivity—Propranolol—migraine	0.000594	0.00375	CcSEcCtD
Lapatinib—Mediastinal disorder—Timolol—migraine	0.000594	0.00375	CcSEcCtD
Lapatinib—Nausea—Amitriptyline—migraine	0.000588	0.00371	CcSEcCtD
Lapatinib—Alopecia—Timolol—migraine	0.000582	0.00367	CcSEcCtD
Lapatinib—Asthenia—Propranolol—migraine	0.000578	0.00365	CcSEcCtD
Lapatinib—Pneumonia—Topiramate—migraine	0.000578	0.00365	CcSEcCtD
Lapatinib—Mental disorder—Timolol—migraine	0.000577	0.00364	CcSEcCtD
Lapatinib—Leukopenia—Valproic Acid—migraine	0.000577	0.00364	CcSEcCtD
Lapatinib—Infestation—Topiramate—migraine	0.000575	0.00363	CcSEcCtD
Lapatinib—Infestation NOS—Topiramate—migraine	0.000575	0.00363	CcSEcCtD
Lapatinib—Malnutrition—Timolol—migraine	0.000574	0.00362	CcSEcCtD
Lapatinib—EGFR—L1CAM interactions—SCN1A—migraine	0.000572	0.022	CbGpPWpGaD
Lapatinib—Cardiac disorder—Gabapentin—migraine	0.000569	0.00359	CcSEcCtD
Lapatinib—Palpitations—Valproic Acid—migraine	0.000569	0.00359	CcSEcCtD
Lapatinib—Neuropathy peripheral—Topiramate—migraine	0.000564	0.00356	CcSEcCtD
Lapatinib—Cough—Valproic Acid—migraine	0.000562	0.00355	CcSEcCtD
Lapatinib—Stomatitis—Topiramate—migraine	0.00056	0.00354	CcSEcCtD
Lapatinib—Immune system disorder—Gabapentin—migraine	0.000554	0.0035	CcSEcCtD
Lapatinib—Mediastinal disorder—Gabapentin—migraine	0.000553	0.00349	CcSEcCtD
Lapatinib—Diarrhoea—Propranolol—migraine	0.000552	0.00348	CcSEcCtD
Lapatinib—Myalgia—Valproic Acid—migraine	0.000549	0.00346	CcSEcCtD
Lapatinib—Arthralgia—Valproic Acid—migraine	0.000549	0.00346	CcSEcCtD
Lapatinib—Hypersensitivity—Verapamil—migraine	0.000546	0.00345	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000545	0.00344	CcSEcCtD
Lapatinib—Epistaxis—Topiramate—migraine	0.000542	0.00342	CcSEcCtD
Lapatinib—Alopecia—Gabapentin—migraine	0.000542	0.00342	CcSEcCtD
Lapatinib—Mental disorder—Gabapentin—migraine	0.000538	0.00339	CcSEcCtD
Lapatinib—Malnutrition—Gabapentin—migraine	0.000534	0.00337	CcSEcCtD
Lapatinib—Asthenia—Verapamil—migraine	0.000532	0.00336	CcSEcCtD
Lapatinib—Anaphylactic shock—Valproic Acid—migraine	0.000526	0.00332	CcSEcCtD
Lapatinib—Pruritus—Verapamil—migraine	0.000525	0.00331	CcSEcCtD
Lapatinib—Infection—Valproic Acid—migraine	0.000522	0.0033	CcSEcCtD
Lapatinib—Back pain—Gabapentin—migraine	0.000517	0.00326	CcSEcCtD
Lapatinib—Nervous system disorder—Valproic Acid—migraine	0.000516	0.00325	CcSEcCtD
Lapatinib—Vomiting—Propranolol—migraine	0.000513	0.00323	CcSEcCtD
Lapatinib—Skin disorder—Valproic Acid—migraine	0.000511	0.00322	CcSEcCtD
Lapatinib—ERBB4—Nuclear signaling by ERBB4—ESR1—migraine	0.00051	0.0196	CbGpPWpGaD
Lapatinib—Rash—Propranolol—migraine	0.000508	0.00321	CcSEcCtD
Lapatinib—Dermatitis—Propranolol—migraine	0.000508	0.0032	CcSEcCtD
Lapatinib—Diarrhoea—Verapamil—migraine	0.000507	0.0032	CcSEcCtD
Lapatinib—Connective tissue disorder—Topiramate—migraine	0.000507	0.0032	CcSEcCtD
Lapatinib—Palpitations—Timolol—migraine	0.000507	0.0032	CcSEcCtD
Lapatinib—Anorexia—Valproic Acid—migraine	0.000501	0.00316	CcSEcCtD
Lapatinib—Cough—Timolol—migraine	0.0005	0.00316	CcSEcCtD
Lapatinib—Anaemia—Gabapentin—migraine	0.000494	0.00311	CcSEcCtD
Lapatinib—Myalgia—Timolol—migraine	0.000488	0.00308	CcSEcCtD
Lapatinib—Arthralgia—Timolol—migraine	0.000488	0.00308	CcSEcCtD
Lapatinib—EGFR—L1CAM interactions—SCN2A—migraine	0.000487	0.0187	CbGpPWpGaD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000485	0.00306	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000479	0.00302	CcSEcCtD
Lapatinib—Cardiac disorder—Topiramate—migraine	0.000479	0.00302	CcSEcCtD
Lapatinib—Nausea—Propranolol—migraine	0.000479	0.00302	CcSEcCtD
Lapatinib—Leukopenia—Gabapentin—migraine	0.000478	0.00302	CcSEcCtD
Lapatinib—Insomnia—Valproic Acid—migraine	0.000476	0.003	CcSEcCtD
Lapatinib—Palpitations—Gabapentin—migraine	0.000472	0.00298	CcSEcCtD
Lapatinib—Vomiting—Verapamil—migraine	0.000472	0.00297	CcSEcCtD
Lapatinib—Dyspnoea—Valproic Acid—migraine	0.000469	0.00296	CcSEcCtD
Lapatinib—Angiopathy—Topiramate—migraine	0.000468	0.00295	CcSEcCtD
Lapatinib—Anaphylactic shock—Timolol—migraine	0.000468	0.00295	CcSEcCtD
Lapatinib—Rash—Verapamil—migraine	0.000468	0.00295	CcSEcCtD
Lapatinib—Dermatitis—Verapamil—migraine	0.000467	0.00295	CcSEcCtD
Lapatinib—Immune system disorder—Topiramate—migraine	0.000466	0.00294	CcSEcCtD
Lapatinib—Cough—Gabapentin—migraine	0.000466	0.00294	CcSEcCtD
Lapatinib—Mediastinal disorder—Topiramate—migraine	0.000465	0.00293	CcSEcCtD
Lapatinib—Infection—Timolol—migraine	0.000465	0.00293	CcSEcCtD
Lapatinib—Headache—Verapamil—migraine	0.000465	0.00293	CcSEcCtD
Lapatinib—Dyspepsia—Valproic Acid—migraine	0.000463	0.00292	CcSEcCtD
Lapatinib—Nervous system disorder—Timolol—migraine	0.000459	0.0029	CcSEcCtD
Lapatinib—Decreased appetite—Valproic Acid—migraine	0.000457	0.00288	CcSEcCtD
Lapatinib—Alopecia—Topiramate—migraine	0.000456	0.00288	CcSEcCtD
Lapatinib—Myalgia—Gabapentin—migraine	0.000455	0.00287	CcSEcCtD
Lapatinib—Arthralgia—Gabapentin—migraine	0.000455	0.00287	CcSEcCtD
Lapatinib—Skin disorder—Timolol—migraine	0.000455	0.00287	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000454	0.00286	CcSEcCtD
Lapatinib—Fatigue—Valproic Acid—migraine	0.000453	0.00286	CcSEcCtD
Lapatinib—Mental disorder—Topiramate—migraine	0.000452	0.00285	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000452	0.00285	CcSEcCtD
Lapatinib—Constipation—Valproic Acid—migraine	0.00045	0.00284	CcSEcCtD
Lapatinib—Malnutrition—Topiramate—migraine	0.000449	0.00283	CcSEcCtD
Lapatinib—ERBB2—ErbB2/ErbB3 signaling events—FOS—migraine	0.000448	0.0172	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—SCN1A—migraine	0.000447	0.0172	CbGpPWpGaD
Lapatinib—Anorexia—Timolol—migraine	0.000446	0.00281	CcSEcCtD
Lapatinib—Nausea—Verapamil—migraine	0.000441	0.00278	CcSEcCtD
Lapatinib—Anaphylactic shock—Gabapentin—migraine	0.000436	0.00275	CcSEcCtD
Lapatinib—ABCB1—trigeminal ganglion—migraine	0.000436	0.00683	CbGeAlD
Lapatinib—Back pain—Topiramate—migraine	0.000435	0.00274	CcSEcCtD
Lapatinib—Infection—Gabapentin—migraine	0.000433	0.00273	CcSEcCtD
Lapatinib—Gastrointestinal pain—Valproic Acid—migraine	0.00043	0.00271	CcSEcCtD
Lapatinib—Nervous system disorder—Gabapentin—migraine	0.000427	0.0027	CcSEcCtD
Lapatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.000427	0.0164	CbGpPWpGaD
Lapatinib—Musculoskeletal discomfort—Timolol—migraine	0.000426	0.00269	CcSEcCtD
Lapatinib—Skin disorder—Gabapentin—migraine	0.000423	0.00267	CcSEcCtD
Lapatinib—Insomnia—Timolol—migraine	0.000423	0.00267	CcSEcCtD
Lapatinib—Dyspnoea—Timolol—migraine	0.000417	0.00263	CcSEcCtD
Lapatinib—Abdominal pain—Valproic Acid—migraine	0.000416	0.00262	CcSEcCtD
Lapatinib—Anorexia—Gabapentin—migraine	0.000416	0.00262	CcSEcCtD
Lapatinib—Anaemia—Topiramate—migraine	0.000415	0.00262	CcSEcCtD
Lapatinib—Dyspepsia—Timolol—migraine	0.000412	0.0026	CcSEcCtD
Lapatinib—Decreased appetite—Timolol—migraine	0.000407	0.00257	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Timolol—migraine	0.000404	0.00255	CcSEcCtD
Lapatinib—Fatigue—Timolol—migraine	0.000404	0.00255	CcSEcCtD
Lapatinib—Leukopenia—Topiramate—migraine	0.000402	0.00254	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Gabapentin—migraine	0.000397	0.00251	CcSEcCtD
Lapatinib—Palpitations—Topiramate—migraine	0.000397	0.0025	CcSEcCtD
Lapatinib—Insomnia—Gabapentin—migraine	0.000394	0.00249	CcSEcCtD
Lapatinib—Cough—Topiramate—migraine	0.000392	0.00247	CcSEcCtD
Lapatinib—Dyspnoea—Gabapentin—migraine	0.000389	0.00245	CcSEcCtD
Lapatinib—Hypersensitivity—Valproic Acid—migraine	0.000387	0.00244	CcSEcCtD
Lapatinib—Dyspepsia—Gabapentin—migraine	0.000384	0.00242	CcSEcCtD
Lapatinib—Gastrointestinal pain—Timolol—migraine	0.000383	0.00241	CcSEcCtD
Lapatinib—Myalgia—Topiramate—migraine	0.000383	0.00241	CcSEcCtD
Lapatinib—Arthralgia—Topiramate—migraine	0.000383	0.00241	CcSEcCtD
Lapatinib—ERBB2—Axon guidance—SCN2A—migraine	0.00038	0.0146	CbGpPWpGaD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00038	0.0024	CcSEcCtD
Lapatinib—Decreased appetite—Gabapentin—migraine	0.000379	0.00239	CcSEcCtD
Lapatinib—Asthenia—Valproic Acid—migraine	0.000377	0.00238	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Gabapentin—migraine	0.000376	0.00237	CcSEcCtD
Lapatinib—Fatigue—Gabapentin—migraine	0.000376	0.00237	CcSEcCtD
Lapatinib—Constipation—Gabapentin—migraine	0.000373	0.00235	CcSEcCtD
Lapatinib—Pruritus—Valproic Acid—migraine	0.000372	0.00235	CcSEcCtD
Lapatinib—Abdominal pain—Timolol—migraine	0.00037	0.00233	CcSEcCtD
Lapatinib—PIK3C2B—EGF/EGFR Signaling Pathway—FOS—migraine	0.000367	0.0141	CbGpPWpGaD
Lapatinib—Infection—Topiramate—migraine	0.000364	0.0023	CcSEcCtD
Lapatinib—Diarrhoea—Valproic Acid—migraine	0.00036	0.00227	CcSEcCtD
Lapatinib—Nervous system disorder—Topiramate—migraine	0.00036	0.00227	CcSEcCtD
Lapatinib—Gastrointestinal pain—Gabapentin—migraine	0.000356	0.00225	CcSEcCtD
Lapatinib—Skin disorder—Topiramate—migraine	0.000356	0.00225	CcSEcCtD
Lapatinib—Anorexia—Topiramate—migraine	0.00035	0.00221	CcSEcCtD
Lapatinib—Hypersensitivity—Timolol—migraine	0.000345	0.00218	CcSEcCtD
Lapatinib—Abdominal pain—Gabapentin—migraine	0.000345	0.00217	CcSEcCtD
Lapatinib—Asthenia—Timolol—migraine	0.000336	0.00212	CcSEcCtD
Lapatinib—Vomiting—Valproic Acid—migraine	0.000334	0.00211	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Topiramate—migraine	0.000334	0.00211	CcSEcCtD
Lapatinib—Insomnia—Topiramate—migraine	0.000332	0.00209	CcSEcCtD
Lapatinib—Rash—Valproic Acid—migraine	0.000332	0.00209	CcSEcCtD
Lapatinib—Dermatitis—Valproic Acid—migraine	0.000331	0.00209	CcSEcCtD
Lapatinib—Pruritus—Timolol—migraine	0.000331	0.00209	CcSEcCtD
Lapatinib—Headache—Valproic Acid—migraine	0.000329	0.00208	CcSEcCtD
Lapatinib—Dyspnoea—Topiramate—migraine	0.000327	0.00206	CcSEcCtD
Lapatinib—ERBB2—Signaling by ERBB4—PGR—migraine	0.000326	0.0125	CbGpPWpGaD
Lapatinib—Dyspepsia—Topiramate—migraine	0.000323	0.00204	CcSEcCtD
Lapatinib—CYP2C8—brain—migraine	0.000322	0.00505	CbGeAlD
Lapatinib—ERBB4—Signaling by ERBB4—PGR—migraine	0.000321	0.0123	CbGpPWpGaD
Lapatinib—Hypersensitivity—Gabapentin—migraine	0.000321	0.00203	CcSEcCtD
Lapatinib—Diarrhoea—Timolol—migraine	0.00032	0.00202	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—SCN1A—migraine	0.000319	0.0123	CbGpPWpGaD
Lapatinib—Decreased appetite—Topiramate—migraine	0.000319	0.00201	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Topiramate—migraine	0.000317	0.002	CcSEcCtD
Lapatinib—Fatigue—Topiramate—migraine	0.000316	0.00199	CcSEcCtD
Lapatinib—ABCB1—cardiovascular system—migraine	0.000315	0.00494	CbGeAlD
Lapatinib—Constipation—Topiramate—migraine	0.000314	0.00198	CcSEcCtD
Lapatinib—Asthenia—Gabapentin—migraine	0.000313	0.00197	CcSEcCtD
Lapatinib—Nausea—Valproic Acid—migraine	0.000312	0.00197	CcSEcCtD
Lapatinib—Pruritus—Gabapentin—migraine	0.000308	0.00195	CcSEcCtD
Lapatinib—ERBB2—Leptin signaling pathway—ESR1—migraine	0.000307	0.0118	CbGpPWpGaD
Lapatinib—Gastrointestinal pain—Topiramate—migraine	0.0003	0.00189	CcSEcCtD
Lapatinib—Diarrhoea—Gabapentin—migraine	0.000298	0.00188	CcSEcCtD
Lapatinib—Vomiting—Timolol—migraine	0.000298	0.00188	CcSEcCtD
Lapatinib—Rash—Timolol—migraine	0.000295	0.00186	CcSEcCtD
Lapatinib—Dermatitis—Timolol—migraine	0.000295	0.00186	CcSEcCtD
Lapatinib—Headache—Timolol—migraine	0.000293	0.00185	CcSEcCtD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000293	0.0112	CbGpPWpGaD
Lapatinib—Abdominal pain—Topiramate—migraine	0.00029	0.00183	CcSEcCtD
Lapatinib—CYP3A4—nervous system—migraine	0.000285	0.00448	CbGeAlD
Lapatinib—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—migraine	0.000282	0.0108	CbGpPWpGaD
Lapatinib—Nausea—Timolol—migraine	0.000278	0.00175	CcSEcCtD
Lapatinib—Vomiting—Gabapentin—migraine	0.000277	0.00175	CcSEcCtD
Lapatinib—CYP3A4—central nervous system—migraine	0.000275	0.00431	CbGeAlD
Lapatinib—Rash—Gabapentin—migraine	0.000275	0.00173	CcSEcCtD
Lapatinib—Dermatitis—Gabapentin—migraine	0.000275	0.00173	CcSEcCtD
Lapatinib—Headache—Gabapentin—migraine	0.000273	0.00172	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—SCN2A—migraine	0.000271	0.0104	CbGpPWpGaD
Lapatinib—Hypersensitivity—Topiramate—migraine	0.00027	0.0017	CcSEcCtD
Lapatinib—Asthenia—Topiramate—migraine	0.000263	0.00166	CcSEcCtD
Lapatinib—Pruritus—Topiramate—migraine	0.000259	0.00164	CcSEcCtD
Lapatinib—Nausea—Gabapentin—migraine	0.000259	0.00163	CcSEcCtD
Lapatinib—Diarrhoea—Topiramate—migraine	0.000251	0.00158	CcSEcCtD
Lapatinib—ERBB2—Developmental Biology—MEF2D—migraine	0.000248	0.00953	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—BDNF—migraine	0.000243	0.00932	CbGpPWpGaD
Lapatinib—Vomiting—Topiramate—migraine	0.000233	0.00147	CcSEcCtD
Lapatinib—Rash—Topiramate—migraine	0.000231	0.00146	CcSEcCtD
Lapatinib—Dermatitis—Topiramate—migraine	0.000231	0.00146	CcSEcCtD
Lapatinib—Headache—Topiramate—migraine	0.00023	0.00145	CcSEcCtD
Lapatinib—PIK3C2B—Metabolism—CACNA1A—migraine	0.000226	0.00865	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000219	0.00841	CbGpPWpGaD
Lapatinib—Nausea—Topiramate—migraine	0.000218	0.00137	CcSEcCtD
Lapatinib—PI4KB—Metabolism—CACNA1A—migraine	0.000218	0.00836	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—SCN1A—migraine	0.000216	0.0083	CbGpPWpGaD
Lapatinib—ABCB1—head—migraine	0.000213	0.00334	CbGeAlD
Lapatinib—ABCB1—nervous system—migraine	0.000202	0.00317	CbGeAlD
Lapatinib—ABCB1—central nervous system—migraine	0.000195	0.00305	CbGeAlD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000194	0.00743	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000194	0.00743	CbGpPWpGaD
Lapatinib—ABCB1—cerebellum—migraine	0.00019	0.00298	CbGeAlD
Lapatinib—EGFR—Axon guidance—SCN2A—migraine	0.000184	0.00706	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—ESR1—migraine	0.000174	0.00669	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—ESR1—migraine	0.000172	0.00659	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—ESR1—migraine	0.00016	0.00615	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—PGR—migraine	0.000158	0.00605	CbGpPWpGaD
Lapatinib—ABCB1—brain—migraine	0.000154	0.00242	CbGeAlD
Lapatinib—EGFR—Developmental Biology—SCN1A—migraine	0.000154	0.00592	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—FOS—migraine	0.000152	0.00582	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—FOS—migraine	0.000149	0.00573	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000145	0.00557	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—FOS—migraine	0.000144	0.00555	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000139	0.00534	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—BDNF—migraine	0.000138	0.00528	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000137	0.00526	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SCN2A—migraine	0.000131	0.00504	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MEF2D—migraine	0.00012	0.00461	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00012	0.00459	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00012	0.00459	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000117	0.0045	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000117	0.0045	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000114	0.00438	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TGFBR2—migraine	0.000108	0.00413	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000106	0.00408	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—migraine	0.000106	0.00408	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—BDNF—migraine	0.000104	0.00398	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—FOS—migraine	0.000102	0.00392	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RAMP1—migraine	0.000101	0.00389	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CALCRL—migraine	0.000101	0.00389	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RAMP1—migraine	9.98e-05	0.00383	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CALCRL—migraine	9.98e-05	0.00383	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	9.36e-05	0.00359	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—FOS—migraine	9.3e-05	0.00357	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	8.73e-05	0.00335	CbGpPWpGaD
Lapatinib—ERBB2—Disease—LRP1—migraine	8.6e-05	0.0033	CbGpPWpGaD
Lapatinib—ERBB4—Disease—LRP1—migraine	8.47e-05	0.00325	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—ESR1—migraine	8.47e-05	0.00325	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—ESR1—migraine	8.42e-05	0.00323	CbGpPWpGaD
Lapatinib—TAP1—Immune System—FOS—migraine	8.37e-05	0.00321	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RAMP1—migraine	8.29e-05	0.00318	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CALCRL—migraine	8.29e-05	0.00318	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	7.47e-05	0.00287	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—MTHFR—migraine	7.46e-05	0.00286	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR1D—migraine	7.36e-05	0.00282	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR1D—migraine	7.25e-05	0.00278	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—FOS—migraine	7.21e-05	0.00277	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—MTHFR—migraine	7.2e-05	0.00276	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	7.19e-05	0.00276	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—migraine	7.03e-05	0.0027	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	7.02e-05	0.00269	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—FOS—migraine	7.01e-05	0.00269	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2B—migraine	6.84e-05	0.00263	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2B—migraine	6.74e-05	0.00259	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	6.72e-05	0.00258	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	6.62e-05	0.00254	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	6.62e-05	0.00254	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LRP1—migraine	6.02e-05	0.00231	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR1D—migraine	6.02e-05	0.00231	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LRP1—migraine	5.93e-05	0.00228	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	5.63e-05	0.00216	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2B—migraine	5.6e-05	0.00215	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CALCA—migraine	5.54e-05	0.00213	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CALCA—migraine	5.46e-05	0.0021	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—FOS—migraine	5.4e-05	0.00207	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—FOS—migraine	5.32e-05	0.00204	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—migraine	5e-05	0.00192	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RAMP1—migraine	4.9e-05	0.00188	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALCRL—migraine	4.9e-05	0.00188	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.72e-05	0.00181	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOTCH4—migraine	4.62e-05	0.00177	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOTCH4—migraine	4.55e-05	0.00175	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFBR2—migraine	4.47e-05	0.00171	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR1B—migraine	4.46e-05	0.00171	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFBR2—migraine	4.4e-05	0.00169	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR1B—migraine	4.39e-05	0.00169	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR1A—migraine	4.29e-05	0.00165	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR1A—migraine	4.23e-05	0.00162	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TAC1—migraine	4.23e-05	0.00162	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NPS—migraine	4.23e-05	0.00162	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PGR—migraine	4.23e-05	0.00162	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NPS—migraine	4.16e-05	0.0016	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PGR—migraine	4.16e-05	0.0016	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TAC1—migraine	4.16e-05	0.0016	CbGpPWpGaD
Lapatinib—EGFR—Disease—LRP1—migraine	4.16e-05	0.0016	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2C—migraine	4.15e-05	0.00159	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2C—migraine	4.08e-05	0.00157	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EDNRA—migraine	4.03e-05	0.00155	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EDNRA—migraine	3.97e-05	0.00152	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOTCH3—migraine	3.93e-05	0.00151	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CALCA—migraine	3.88e-05	0.00149	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOTCH3—migraine	3.87e-05	0.00149	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CALCA—migraine	3.82e-05	0.00147	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—migraine	3.77e-05	0.00145	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR1B—migraine	3.65e-05	0.0014	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR7—migraine	3.63e-05	0.00139	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MTHFR—migraine	3.63e-05	0.00139	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR7—migraine	3.58e-05	0.00137	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MTHFR—migraine	3.57e-05	0.00137	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR1D—migraine	3.56e-05	0.00137	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.54e-05	0.00136	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR1A—migraine	3.51e-05	0.00135	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—migraine	3.48e-05	0.00133	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TAC1—migraine	3.46e-05	0.00133	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NPS—migraine	3.46e-05	0.00133	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.4e-05	0.0013	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2C—migraine	3.39e-05	0.0013	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2B—migraine	3.31e-05	0.00127	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—EDNRA—migraine	3.3e-05	0.00127	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—migraine	3.29e-05	0.00126	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CALCA—migraine	3.18e-05	0.00122	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FOS—migraine	3.15e-05	0.00121	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFBR2—migraine	3.13e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FOS—migraine	3.1e-05	0.00119	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFBR2—migraine	3.08e-05	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR7—migraine	2.97e-05	0.00114	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CACNA1A—migraine	2.97e-05	0.00114	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LRP1—migraine	2.91e-05	0.00112	CbGpPWpGaD
Lapatinib—EGFR—Disease—CALCA—migraine	2.68e-05	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FOS—migraine	2.61e-05	0.001	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CACNA1A—migraine	2.57e-05	0.000987	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2A—migraine	2.54e-05	0.000976	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2A—migraine	2.5e-05	0.000961	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CACNA1A—migraine	2.3e-05	0.000881	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ESR1—migraine	2.26e-05	0.000866	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CACNA1A—migraine	2.24e-05	0.00086	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH4—migraine	2.23e-05	0.000858	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ESR1—migraine	2.22e-05	0.000853	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFBR2—migraine	2.16e-05	0.000828	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR1B—migraine	2.16e-05	0.000827	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2A—migraine	2.08e-05	0.000799	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR1A—migraine	2.08e-05	0.000796	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PGR—migraine	2.04e-05	0.000784	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAC1—migraine	2.04e-05	0.000784	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NPS—migraine	2.04e-05	0.000784	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2C—migraine	2e-05	0.000769	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EDNRA—migraine	1.95e-05	0.000748	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH3—migraine	1.9e-05	0.000729	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALCA—migraine	1.88e-05	0.00072	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR7—migraine	1.76e-05	0.000674	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—migraine	1.75e-05	0.000673	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.72e-05	0.000659	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—migraine	1.59e-05	0.00061	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FOS—migraine	1.52e-05	0.000584	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFBR2—migraine	1.51e-05	0.00058	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CACNA1A—migraine	1.38e-05	0.00053	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—migraine	1.23e-05	0.000472	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ESR1—migraine	1.09e-05	0.000419	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—migraine	9.82e-06	0.000377	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—migraine	8.51e-06	0.000326	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—migraine	7.59e-06	0.000291	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—migraine	7.41e-06	0.000284	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—migraine	4.57e-06	0.000175	CbGpPWpGaD
